Agarwal Arjun's Form 4 filing
Oruka Therapeutics, Inc. (ORKA) · filed Sep 15, 2026
- Accession no.
- 0000907654-26-000097
- Filed
- Sep 15, 2026, 7:17 PM ET
- Trade date
- Sep 11-15, 2026
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Checked
This filing lists 7 non-derivative transactions and 2 derivative transactions. Open-market sales total $926.0K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Agarwal ArjunCIK 0002033974 | Officer (Senior Vice President, Finance) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 11, 2026 | Common Stock | MOption exerciseAcquired | +8,000 | $12.50 | +$100,000 | 23,312 | Direct | |
| Sep 11, 2026 | Common Stock | MOption exerciseAcquired | +1,459 | $34.39 | +$50,175.01 | 24,771 | Direct | |
| Sep 11, 2026 | Common Stock | SSaleDisposed | −3,000 | $91.11 | −$273,321.9 | 21,771 | Direct | |
| Sep 11, 2026 | Common Stock | SSaleDisposed | −4,051 | $92.41 | −$374,367.09 | 17,720 | Direct | |
| Sep 11, 2026 | Common Stock | SSaleDisposed | −2,208 | $93.26 | −$205,920.51 | 15,512 | Direct | |
| Sep 11, 2026 | Common Stock | SSaleDisposed | −200 | $94.02 | −$18,803 | 15,312 | Direct | |
| Sep 15, 2026 | Common Stock | SSaleDisposed | −560 | $95.71 | −$53,597.6 | 14,752 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 11, 2026 | Common Stock | MOption exerciseDisposed | −8,000 | $0.00 | $0 | 84,917 | Direct | |
| Sep 11, 2026 | Common Stock | MOption exerciseDisposed | −1,459 | $0.00 | $0 | 58,333 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.